A tailored course, built for your situation
Compliance-Ready AI in Pharmaceutical R&D Operations
Implementation-grade mastery for technology and business leaders in high-growth pharma organizations
The situation this course is for
High-growth pharmaceutical organizations are advancing AI use in drug discovery, clinical trial design, and development operations. However, deploying these systems while maintaining GLP, GCP, and 21 CFR Part 11 compliance introduces complexity. Teams face pressure to innovate quickly while ensuring data integrity, traceability, and validation standards are met. Generic AI training doesn't address the regulatory scaffolding required, leading to rework, delays, or failed audits.
Who this is for
Business and technology professionals in mid-to-senior roles within pharmaceutical R&D, regulatory operations, data governance, or AI strategy who are tasked with scaling compliant AI systems in fast-moving environments.
Who this is not for
Entry-level staff without decision-making authority, professionals outside regulated life sciences, or those seeking theoretical AI overviews without implementation focus.
What you walk away with
- Architect AI workflows that maintain compliance from development through validation
- Apply audit-ready documentation practices specific to AI model lifecycle management
- Integrate AI into regulated R&D pipelines without violating data integrity standards
- Lead cross-functional initiatives with confidence in regulatory boundaries and opportunities
- Scale AI solutions across teams while preserving compliance posture
The 12 modules (with all 144 chapters)
- Defining AI in the context of drug development
- Regulatory expectations for algorithmic transparency
- Distinguishing research-grade from production-grade AI
- Ethical considerations in AI-driven discovery
- Data provenance and lineage requirements
- Role of validation in AI model deployment
- Overview of GxP implications
- AI and the ALCOA+ principles
- Change control in AI systems
- Version control for models and data
- Documentation standards for audit readiness
- Common misconceptions about AI compliance
- FDA guidance on AI in clinical development
- EMA perspectives on machine learning validation
- ICH Q9 and risk management integration
- 21 CFR Part 11 and electronic records
- GDPR implications for R&D data
- Data privacy across jurisdictions
- Inspection readiness for AI systems
- Audit trails for algorithmic decision-making
- Regulatory submissions with AI components
- Labeling considerations for AI-aided development
- Interpreting emerging compliance trends
- Preparing for regulatory queries
- Defining model purpose and intended use
- Data sourcing under GxP constraints
- Training data quality assurance
- Model selection with auditability in mind
- Validation planning for machine learning
- Establishing performance benchmarks
- Documentation at each lifecycle stage
- Change management for model updates
- Retraining and version control
- Model monitoring in production
- Decommissioning AI models
- Lifecycle integration with QMS
- Applying ALCOA+ to AI data pipelines
- Data qualification vs validation
- Metadata requirements for AI models
- Data transformation documentation
- Handling missing or incomplete data
- Audit trail generation for data flows
- Data retention policies
- Access control for training datasets
- Data anonymization techniques
- Data lineage tools and practices
- Versioning datasets
- Ensuring reproducibility
- Differences between traditional and AI validation
- Defining acceptance criteria for models
- Prospective vs retrospective validation
- Cross-validation in regulated settings
- Performance monitoring metrics
- Handling model drift
- Establishing revalidation triggers
- Validation documentation structure
- Testing in silico models
- Validation of third-party AI tools
- Vendor qualification for AI components
- Ongoing validation in agile environments
- Change control for model updates
- Assessing impact of data changes
- Documentation of model retraining
- Handling unexpected model behavior
- Deviation reporting for AI outputs
- Root cause analysis for model failures
- Risk assessment of proposed changes
- Approval workflows for AI modifications
- Version rollback procedures
- Communication of changes to stakeholders
- Audit readiness for change logs
- Integration with CAPA systems
- Patient recruitment optimization
- Predictive enrollment modeling
- Adaptive trial design considerations
- AI for endpoint selection
- Bias detection in trial populations
- Data monitoring committees and AI
- Safety signal detection algorithms
- Regulatory expectations for trial AI
- Documentation of AI-assisted decisions
- Informed consent implications
- Audit trails for trial data adjustments
- Post-hoc analysis with AI
- Virtual screening with machine learning
- Predictive toxicity modeling
- Lead optimization using AI
- Data quality in high-throughput screening
- Model interpretability in discovery
- Collaboration between AI and medicinal chemists
- Validation of in silico models
- Documentation of AI-generated hypotheses
- IP considerations for AI-driven discoveries
- Reproducibility across labs
- Data sharing with partners
- Regulatory expectations for discovery-stage AI
- Standardizing AI workflows
- Centralized model repositories
- Governance frameworks for AI
- Cross-team collaboration models
- Training and onboarding for AI tools
- Performance monitoring at scale
- Resource allocation for AI projects
- Budgeting for AI infrastructure
- Vendor management for AI platforms
- Integration with existing IT systems
- Change management for organization-wide AI
- Scaling documentation practices
- Preparing AI documentation for inspection
- Common findings in AI-related audits
- Demonstrating model validation
- Presenting data lineage to auditors
- Handling auditor questions on AI
- Internal audit preparation
- Mock inspection exercises
- Corrective action plans for AI findings
- Audit trail completeness
- Personnel training for audit readiness
- Documentation accessibility
- Post-inspection follow-up
- Bridging technical and regulatory teams
- Translating AI capabilities for leadership
- Stakeholder alignment strategies
- Managing expectations across functions
- Resource negotiation for AI projects
- Communicating risks and benefits
- Building AI competency across teams
- Fostering innovation within compliance boundaries
- Strategic roadmap development
- Success metrics for AI initiatives
- Conflict resolution in AI projects
- Sustaining momentum in long-term AI efforts
- Monitoring regulatory developments
- Adapting to new AI guidelines
- Emerging technologies in R&D
- Preparing for AI-specific regulations
- Ethical review board engagement
- Sustainability in AI infrastructure
- AI and environmental impact
- Workforce transformation with AI
- Succession planning for AI roles
- Knowledge transfer in AI teams
- Long-term data management strategies
- Strategic retirement of legacy AI systems
How this maps to your situation
- Scaling AI beyond pilot phases
- Preparing for regulatory inspection
- Integrating AI into validated environments
- Leading cross-functional AI initiatives
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 3 hours per module, designed for professionals to complete at their own pace over 8-12 weeks.
How this compares to the alternatives
Unlike generic AI courses, this program focuses exclusively on implementation in regulated pharmaceutical R&D. It goes beyond theory to provide audit-ready frameworks, templates, and compliance patterns not available in MOOCs or vendor training.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.